Transformez ce poste en entretien — un CV et une lettre de motivation conçus selon ce que cet employeur recherche.
Evotec in Toulouse seeks a Research Scientist (Computational Biology) to support oncology projects through bioinformatics and data analysis. The role requires a PhD with postdoc/industry experience and strong R skills.
You will collaborate across biology and data science teams in a fast-paced environment, applying omics analysis to drug discovery and platform development.
In the AI In Silico R&D Department at Evotec, more than 100 scientists from diverse backgrounds in biology, computer science, mathematics, and biomedicine work together to analyze and interpret complex omics datasets. In close collaboration with our laboratory scientists, we develop, operate, and continuously enhance high-throughput, high-precision omics platforms. As part of multidisciplinary drug discovery programs, we collaborate with experts from a wide range of scientific disciplines across a global organization of more than 5,000 employees worldwide. Our work spans omics data management and quality control, method and software development, advanced data analysis, and the biological interpretation of results. Our mission is to generate actionable insights that enable better decisions and accelerate the development of medicines that matter. To strengthen our Computational Oncology Group, we are looking for a highly motivated Research Scientist (all genders) - Computational Biology Full-time and permanent
FR : Dans le cadre de sa politique Diversité, Evotec étudie, à compétences égales, toutes les candidatures dont celles des personnes en situation de handicap.
ENG : In the frame of our Diversity policy, Evotec considers, with equal competences, all applications including people with disabilities.
Evotec is a life science company with a unique business model that delivers on its mission to discover and develop highly effective therapeutics and make them available to the patients. The Company’s multimodality platform comprises a unique combination of innovative technologies, data and science for the discovery, development, and production of first-in-class and best-in-class pharmaceutical products. Evotec leverages this “Data-driven R&D Autobahn to Cures” for proprietary projects and within a network of partners including all Top 20 Pharma and over 800 biotechnology companies, academic institutions, as well as other healthcare stakeholders. Evotec has strategic activities in a broad range of currently underserved therapeutic areas, including e.g. neurology, oncology, as well as metabolic and infectious diseases. Within these areas of expertise, Evotec aims to create the world-leading co-owned pipeline for innovative therapeutics and has to-date established a portfolio of more than 200 proprietary and co-owned R&D projects from early discovery to clinical development. Evotec operates globally with more than 5,000 highly qualified people. The Company’s 17 sites offer highly synergistic technologies and services and operate as complementary clusters of excellence.
For additional information please go to www.evotec.com and follow us on X/Twitter @Evotec and LinkedIn.